Objectives-Insulin activates several processes potentially dangerous for the arterial wall and hyperinsulinemia might be atherogenic. However, other insulin effects are protective for the vessel wall and thus anti-atherogenic. Aim of this study was to investigate whether insulin effects on potentially pro-atherogenic and anti-atherogenic processes were differently affected in cells from insulin-resistant individuals. Methods and Results-We determined insulin effect on nitric oxide (NO) production and plasminogen activator inhibitor (PAI)-1 synthesis in 12 fibroblast strains obtained from skin biopsy samples of 6 insulin-sensitive (IS) (clamp M Ͼ7 mg/kg body weight per minute) and 6 insulin-resistant (IR) (clamp M Ͻ5 mg/kg body weight per minute) healthy volunteers. Insulin effects on NO release and Akt phosphorylation were significantly impaired in fibroblasts from IR as compared with IS individuals. Conversely, there was not any difference between IR and IS strains in insulin ability to increase PAI-1 antigen levels and, after 24-hour insulin incubation, PAI-1 mRNA increase in IR strains was only slightly less than in IS strains. Insulin ability to induce MAPK activation was also comparable in IR and IS cells. Conclusions-We conclude that in cells from IR individuals, insulin action on anti-atherogenic processes, such as NO release, is impaired, whereas the hormone ability to stimulate atherogenic processes, such as PAI-1 release, is preserved. Key Words: diabetes mellitus Ⅲ fibroblasts Ⅲ insulin resistance Ⅲ nitric oxide Ⅲ plasminogen activator inhibitor type 1 M etabolic syndrome is characterized by insulin resistance, hyperinsulinemia, and a cluster of risk factors for cardiovascular disease. Because insulin can activate several processes potentially dangerous for the vascular wall, hyperinsulinemia might contribute to the high cardiovascular risk associated with the syndrome. [1][2][3][4][5] As a matter of fact, insulin promotes vascular smooth muscle cells migration, 6 enhances leukocyte adhesion molecules expression, 7 stimulates endothelin 8 and plasminogen activator inhibitor-1 (PAI-1) 9 -11 synthesis and expression. However, several insulin effects could be considered protective for the vessel wall and thus anti-atherogenic; for instance, insulin inhibits platelet aggregation 12 and stimulates nitric oxide (NO) release. 13,14 In insulin-resistant subjects, molecular pathways leading to the potentially protective insulin effects on the vessel wall could be insulin-resistant as well, thus contributing to the accelerated atherosclerosis associated with insulin resistance. As a matter of fact, different intracellular cascades can transduce insulin signaling 15 and it appears that most of the potentially proatherogenic insulin effects (cell growth stimulation, increased PAI-1 synthesis and expression, etc.) are mainly mediated through a MAPK-dependent signaling pathway, 16 -19 whereas insulin effects on glucose transport and glucose uptake as well as insulin stimulation of NO synthesis and release are me...